KYNTRA BIO, INC.【KYNB】Balance sheet

Market cap

$28.19M

P/E ratio

	2015/12	2016/12	2017/12	2018/12	2019/12	2020/12	2021/12	2022/12	2023/12	2024/12
Cash and cash equivalents	153	174	674	89	126	678	171	156	114	50
Marketable securities, current	28	79	124	532	407	8	234	266	122	-
Total cash & short-term investments	181	253	798	621	534	687	405	422	236	50
Accounts receivable, net	15	10	8	64	28	42	17	16	13	0
Inventories	-	-	-	-	7	17	31	40	42	3
Total current assets	201	267	749	690	702	755	474	493	332	197
Property, plant and equipment, net	129	124	129	127	43	34	28	21	13	-
Marketable securities, non-current	132	71	11	56	61	0	-	-	-	-
Total non-current assets	270	203	150	191	155	72	300	117	92	18
Total assets	471	470	899	881	857	827	774	610	424	215
Accounts payable	7	6	6	9	6	25	26	31	18	5
Total current liabilities	67	65	77	89	103	163	225	274	218	133
Total non-current liabilities	207	229	239	263	219	222	319	338	368	265
Total liabilities	274	294	316	352	322	385	545	612	586	398
Common stock and paid-in capital	587	1	1,161	1,227	1,302	1,401	1,477	1,542	1,645	1,670
Retained earnings	-408	-470	-596	-716	-785	-974	-1,264	-1,558	-1,842	-1,889
Stockholders' equity	197	175	582	528	535	441	229	-1	-184	-205
Working capital	-	-	-	-